Abstract
An oligosaccharide fraction isolated from the mycelium of the Lingzhi or Reishi medicinal mushroom Ganoderma lucidum (GLOS) was separated by size-exclusion chromatography. The chemical structure of GLOS consists of a disaccharide repeating unit [-4-β-1-Galf(1-6)-O-(β-Glcp)-1-]n (n=3,4). In addition, this study was undertaken to determine the possible anticonvulsant and neuroprotective effects of GLOS (10-80 mg/kg) on kainic acid (KA)-induced seizures. The behavioral alterations and histopathology of hippocampal neurons were studied. Our results show that GLOS inhibited convulsions in rats from KA-induced seizures, reduced the degeneration pattern in the CA3 region of rats, decreased astrocytic reactivity, and reduced the expression of IL-1β and TNF-α induced by KA. These results indicate a potential anticonvulsant and neuroprotective effects of GLOS.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Animals
-
Anticonvulsants / pharmacology
-
Anticonvulsants / therapeutic use*
-
Behavior, Animal / drug effects
-
Biological Products / isolation & purification
-
Biological Products / pharmacology
-
Biological Products / therapeutic use
-
Brain / drug effects*
-
Brain / metabolism
-
Brain / pathology
-
Drugs, Chinese Herbal / chemistry
-
Drugs, Chinese Herbal / pharmacology
-
Drugs, Chinese Herbal / therapeutic use*
-
Interleukin-1beta / metabolism
-
Kainic Acid
-
Male
-
Mycelium
-
Neuroprotective Agents / pharmacology
-
Neuroprotective Agents / therapeutic use*
-
Oligosaccharides / isolation & purification
-
Oligosaccharides / pharmacology
-
Oligosaccharides / therapeutic use*
-
Rats
-
Rats, Wistar
-
Reishi / chemistry*
-
Seizures / chemically induced
-
Seizures / drug therapy*
-
Seizures / metabolism
-
Seizures / pathology
-
Tumor Necrosis Factor-alpha / metabolism
Substances
-
Anticonvulsants
-
Biological Products
-
Drugs, Chinese Herbal
-
Interleukin-1beta
-
Neuroprotective Agents
-
Oligosaccharides
-
Tumor Necrosis Factor-alpha
-
Kainic Acid